Drugs / CoV2 preS dTM-AS03
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04537208 | Sep 2020 → Nov 2021 | — | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CoV2 preS dTM-AS03 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04537208 ↗ |